HUTCHMED (China) Limited (HKG:0013)
Hong Kong · Delayed Price · Currency is HKD 27.68
-0.32 (-1.14%)
Sep 15, 2025, 4:08 PM HKT
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of 22.73 billion as of September 15, 2025. Its market cap has decreased by -2.46% in one year.
Market Cap
22.73B
Enterprise Value
13.06B
Revenue
4.73B
Ranking
n/a
PE Ratio
6.20
Stock Price
27.68
Market Cap Chart
Since May 19, 2006, HUTCHMED (China)'s market cap has increased from 1.87B to 22.73B, an increase of 1,117.90%. That is a compound annual growth rate of 13.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 23.56B | 20.64% |
| Dec 31, 2024 | 19.53B | -18.73% |
| Dec 29, 2023 | 24.03B | 14.66% |
| Dec 30, 2022 | 20.96B | -56.27% |
| Dec 31, 2021 | 47.93B | 35.91% |
| Dec 31, 2020 | 35.26B | 35.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 278.04B |
| JD Health International | 222.02B |
| Hansoh Pharmaceutical Group Company | 215.52B |
| Innovent Biologics | 167.59B |
| Sino Biopharmaceutical | 154.34B |
| WuXi Biologics | 148.25B |
| Akeso | 124.81B |
| CSPC Pharmaceutical Group | 118.33B |